Epigenetic silencing of somatostatin in gastric cancer

Digestive Diseases and Sciences

Volumn 56, Issue 1, 2011, Pages 125-130

  Jackson, Kaya ^a   Soutto, Mohammed ^b   Peng, Dunfa ^b   Hu, Tianling ^b   Marshal, Dana ^a   El Rifai, Wael ^b,c  

^a MEHARRY MEDICAL COLLEGE   (United States)

^b VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^c VANDERBILT INGRAM CANCER CENTER   (United States)

Author keywords

Expression; Gastric cancer; Methylation; Somatostatin

Indexed keywords

5 AZA 2' DEOXYCYTIDINE; BISULFITE; SOMATOSTATIN; TRICHOSTATIN A;

ARTICLE; CLINICAL EVALUATION; CPG ISLAND; DIAGNOSTIC TEST ACCURACY STUDY; DNA METHYLATION; DOWN REGULATION; DRUG POTENTIATION; EPIGENETICS; GENE CONTROL; GENE EXPRESSION; GENE SILENCING; GENETIC TRANSCRIPTION; HUMAN; HUMAN TISSUE; PREDICTIVE VALUE; PRIORITY JOURNAL; PYROSEQUENCING; REAL TIME POLYMERASE CHAIN REACTION; STOMACH ADENOCARCINOMA; STOMACH CARCINOGENESIS;

ADENOCARCINOMA; ANTINEOPLASTIC AGENTS; AZACITIDINE; CELL LINE, TUMOR; DNA METHYLATION; EPIGENESIS, GENETIC; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; HYDROXAMIC ACIDS; METHYLATION; PREDICTIVE VALUE OF TESTS; REPRODUCIBILITY OF RESULTS; RNA, MESSENGER; SOMATOSTATIN; STOMACH NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 79151479007     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10620-010-1422-z     Document Type: Article

References (24)

1. KD Crew AI Neugut 2006 Epidemiology of gastric cancer World J Gastroenterol 12 354 362 16489633
2. LE Hansson P Sparen O Nyren 1993 Increasing incidence of carcinoma of the gastric cardia in Sweden from 1970 to 1985 Br J Surg 80 374 377 1:STN:280:DyaK3s3jtVCjug%3D%3D 10.1002/bjs.1800800338 8472157
3. DM Roder 2002 The epidemiology of gastric cancer Gastric Cancer 5 Suppl 1 5 11 10.1007/s10120-002-0203-6 12772880
4. P Hohenberger S Gretschel 2003 Gastric cancer Lancet 362 305 315 10.1016/S0140-6736(03)13975-X 12892963
5. R Berardi M Scartozzi E Galizia S Cascinu 2003 Adjuvant chemotherapy in gastric cancer. The italian experience and review of the literature Suppl Tumori 2 S45 S47 12914390
6. PA Jones 2003 Epigenetics in carcinogenesis and cancer prevention Ann N Y Acad Sci 983 213 219 1:CAS:528:DC%2BD3sXjt1yrsLY%3D 10.1111/j.1749-6632.2003. tb05976.x 12724226
7. SB Baylin JE Ohm 2006 Epigenetic gene silencing in cancer-a mechanism for early oncogenic pathway addiction? Nat Rev Cancer 6 107 116 1:CAS:528:DC%2BD28Xht1eiurw%3D 10.1038/nrc1799 16491070
8. PA Jones SB Baylin 2002 The fundamental role of epigenetic events in cancer Nat Rev Genet 3 415 428 1:CAS:528:DC%2BD38XksFOmsrw%3D 10.1038/nrg962 12042769
9. Z Jin Y Mori JP Hamilton A Olaru F Sato J Yang T Ito T Kan R Agarwal SJ Meltzer 2008 Hypermethylation of the somatostatin promoter is a common, early event in human esophageal carcinogenesis Cancer 112 43 49 1:CAS:528: DC%2BD1cXhtlSisL0%3D 10.1002/cncr.23135 17999418
10. Y Mori K Cai Y Cheng S Wang B Paun JP Hamilton Z Jin F Sato AT Berki T Kan T Ito C Mantzur JM Abraham SJ Meltzer 2006 A genome-wide search identifies epigenetic silencing of somatostatin, tachykinin-1, and 5 other genes in colon cancer Gastroenterology 131 797 808 1:CAS:528:DC%2BD28XhtVKrurnM 10.1053/j.gastro.2006.06.006 16952549
11. RA Liddle RL Jirtle 2006 Epigenetic silencing of genes in human colon cancer Gastroenterology 131 960 962 1:CAS:528:DC%2BD28XhtVKrurbJ 10.1053/j.gastro.2006.07.028 16952566
12. JC Reubi JA Laissue 1995 Multiple actions of somatostatin in neoplastic disease Trends Pharmacol Sci 16 110 115 1:CAS:528:DyaK2MXltlSku78%3D 10.1016/S0165-6147(00)88992-0 7792931
13. W El-Rifai CA Moskaluk M Abdrabbo JC Harper C Yoshida G Riggins HF Frierson Jr SM Powell 2002 Gastric cancers overexpress s100a calcium binding proteins Cancer Res 62 6823 6826 1:CAS:528:DC%2BD38XpsVahsrc%3D 12460893
14. EE Cameron KE Bachman S Myohanen JG Herman SB Baylin 1999 Synergy of demethylation and histone deacetylase inhibition in the re-expression of genes silenced in cancer Nat Genet 21 103 107 1:CAS:528:DyaK1MXltlWjtA%3D%3D 10.1038/5047 9916800
15. JN Ou J Torrisani A Unterberger N Provencal K Shikimi M Karimi TJ Ekstrom M Szyf 2007 Histone deacetylase inhibitor trichostatin a induces global and gene-specific DNA demethylation in human cancer cell lines Biochem Pharmacol 73 1297 1307 1:CAS:528:DC%2BD2sXjsVGitL8%3D 10.1016/j.bcp.2006.12.032 17276411
16. LP Wu X Wang L Li Y Zhao S Lu Y Yu W Zhou X Liu J Yang Z Zheng H Zhang J Feng Y Yang H Wang WG Zhu 2008 Histone deacetylase inhibitor depsipeptide activates silenced genes through decreasing both cpg and h3k9 methylation on the promoter Mol Cell Biol 28 3219 3235 1:CAS:528:DC%2BD1cXlvFeru7g%3D 10.1128/MCB.01516-07 18332107
17. Y Xiong SC Dowdy KC Podratz F Jin JR Attewell NL Eberhardt SW Jiang 2005 Histone deacetylase inhibitors decrease DNA methyltransferase-3b messenger rna stability and down-regulate de novo DNA methyltransferase activity in human endometrial cells Cancer Res 65 2684 2689 1:CAS:528:DC%2BD2MXjtVeqsLk%3D 10.1158/0008-5472.CAN-04-2843 15805266
18. X Yang DL Phillips AT Ferguson WG Nelson JG Herman NE Davidson 2001 Synergistic activation of functional estrogen receptor (er)-alpha by DNA methyltransferase and histone deacetylase inhibition in human er-alpha-negative breast cancer cells Cancer Res 61 7025 7029 1:CAS:528:DC%2BD3MXnsVehsrs%3D 11585728
19. DF Peng M Razvi H Chen K Washington A Roessner R Schneider-Stock W El-Rifai 2009 DNA hypermethylation regulates the expression of members of the mu-class glutathione s-transferases and glutathione peroxidases in Barrett's adenocarcinoma Gut 58 5 15 1:CAS:528:DC%2BD1MXhs1SktL8%3D 10.1136/gut.2007. 146290 18664505
20. OJ Lee R Schneider-Stock PA McChesney D Kuester A Roessner M Vieth CA Moskaluk W El-Rifai 2005 Hypermethylation and loss of expression of glutathione peroxidase-3 in Barrett's tumorigenesis Neoplasia 7 854 861 1:CAS:528: DC%2BD2MXhtlClurfO 10.1593/neo.05328 16229808
21. D Deng W El-Rifai J Ji B Zhu P Trampont J Li MF Smith SM Powel 2003 Hypermethylation of metallothionein-3 cpg island in gastric carcinoma Carcinogenesis 24 25 29 1:CAS:528:DC%2BD3sXitlCgtL8%3D 10.1093/carcin/24.1.25 12538345
22. Schneider BG, Peng DF, Camargo MC, Piazuelo MB, Sicinschi LA, Mera R, Romero-Gallo J, Delgado AG, Bravo LE, Wilson KT, Peek RM, Jr., Correa P, El-Rifai W: Promoter DNA hypermethylation in gastric biopsies from subjects at high and low risk for gastric cancer. Int J Cancer. 2010. doi: 10.1002/ijc.25274.
23. CA Eads RV Lord K Wickramasinghe TI Long SK Kurumboor L Bernstein JH Peters SR DeMeester TR DeMeester KA Skinner PW Laird 2001 Epigenetic patterns in the progression of esophageal adenocarcinoma Cancer Res 61 3410 3418 1:CAS:528:DC%2BD3MXjtFSjurk%3D 11309301
24. G Clement R Braunschweig N Pasquier FT Bosman J Benhattar 2006 Alterations of the wnt signaling pathway during the neoplastic progression of Barrett's esophagus Oncogene 25 3084 3092 1:CAS:528:DC%2BD28Xks1Orsb0%3D 10.1038/sj.onc.1209338 16407829